Invention Grant
- Patent Title: Antibodies to PMEL17 and conjugates thereof
-
Application No.: US16718866Application Date: 2019-12-18
-
Publication No.: US11779649B2Publication Date: 2023-10-10
- Inventor: Matthew Burger , Joseph Anthony D'Alessio , Tony Fleming , Vivek Rauniyar , Eusebio Manchado Robles , Christian Kunz , Markus Waldhuber
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: K&L Gates LLP
- Main IPC: A61K47/68
- IPC: A61K47/68 ; A61P35/00 ; A61K31/4745 ; C07K16/18 ; A61K45/06

Abstract:
This application discloses anti-PMEL17 antibodies, antigen binding fragments thereof, and antibody drug conjugates comprising antibodies or antigen binding fragments conjugated to a GNAQ/GNA11 inhibitor. The application also discloses methods of treating or preventing cancer using the antibodies, antigen binding fragments, and antibody drug conjugates. Also disclosed herein are methods of making the antibodies, antigen binding fragments, and antibody drug conjugates, and methods of using the antibodies and antigen binding fragments as diagnostic reagents.
Information query
IPC分类: